ACVR2A Gene

Last updated on: 15.04.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

ACVR2A (ACVR2A stands for: Activin A Receptor Type 2A) is a protein coding gene located on chromosome 2q22.3-q23.1.

The ACVR2A gene encodes a receptor that mediates the functions of activins (activin A, activin B, and inhibin A/Renlund N et al. 2007). which belong to the transforming growth factor (TGF-beta) superfamily and are involved in various biological processes.

The encoded receptor protein is a transmembrane serine-threonine kinase receptor that mediates signals by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The receptor complexes formed consist of two type II and two type I transmembrane kinases (serine/threonine kinases). The type II receptors phosphorylate and activate type I receptors, which autophosphorylate and then bind and activate SMAD transcriptional regulators. The encoded type II receptor is primarily involved in ligand binding and includes an extracellular ligand-binding domain, a transmembrane domain, and a cytoplasmic serine/threonine kinase domain.

General informationThis section has been translated automatically.

The ACVR2A gene is associated with susceptibility to preeclampsia, a pregnancy-related condition that can lead to maternal and fetal morbidity and mortality. Diseases associated with ACVR2A include fibrodysplasia ossificans progressiva. Animal experiments have shown that decreased activity of Bmpr2 and Acvr2 lead to early graying (Han R et al. 2012).

LiteratureThis section has been translated automatically.

  1. Han R et al. (2012) Apair of transmembrane receptors essential for the retention and pigmentation of hair. Genesis 50:783-800.
  2. Renlund N et al (2007) Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor. J Endocrinol 195: 95-103.

Last updated on: 15.04.2023